Our approach

We identified seven blood biomarkers that reliably diagnose AD.

The biomarkers are cytokines and growth factors which have been selected based on their involvement in neuroprotective or neurodegenerative processes or based on their general association with the immune system in neurological diseases, specifically with AD.